286 related articles for article (PubMed ID: 15997630)
1. [Serum gamma-glutamyl transpeptidase activity in children with chronic hepatitis B].
Lebensztejn DM; Skiba E; Sobaniec-Lotowska ME; Kaczmarski M
Pol Merkur Lekarski; 2005 Mar; 18(105):271-4. PubMed ID: 15997630
[TBL] [Abstract][Full Text] [Related]
2. [Clinical significance of serum glutamyl transpeptidase in chronic hepatitis B].
Xian YC; Yang JY; Xu R; Huang CJ; Wu LL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Dec; 21(4):383-5. PubMed ID: 18322611
[TBL] [Abstract][Full Text] [Related]
3. Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis?
Vardar R; Vardar E; Demiri S; Sayhan SE; Bayol U; Yildiz C; Postaci H
Hepatogastroenterology; 2009; 56(94-95):1459-65. PubMed ID: 19950810
[TBL] [Abstract][Full Text] [Related]
4. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
Park JH; Park CK; Kim ES; Park SY; Jo CM; Tak WY; Kweon YO; Kim SK; Choi YW
Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
[TBL] [Abstract][Full Text] [Related]
5. The relation between liver histopathology and GGT levels in viral hepatitis: more important in hepatitis B.
Eminler AT; Irak K; Ayyildiz T; Keskin M; Kiyici M; Gurel S; Gulten M; Dolar E; Nak SG
Turk J Gastroenterol; 2014 Aug; 25(4):411-5. PubMed ID: 25254524
[TBL] [Abstract][Full Text] [Related]
6. [The value of gamma-glutamyltransferase in the diagnosis of chronic hepatitis B].
Wang G; Liu M; Jiang X; Ming L; Xie Q
Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):120-2. PubMed ID: 11983131
[TBL] [Abstract][Full Text] [Related]
7. Correlation of liver biochemistry with liver stiffness in chronic hepatitis B and development of a predictive model for liver fibrosis.
Fung J; Lai CL; Fong DY; Yuen JC; Wong DK; Yuen MF
Liver Int; 2008 Dec; 28(10):1408-16. PubMed ID: 18482268
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive serum markers in the diagnosis of structural liver damage in chronic hepatitis C virus infection.
Parise ER; Oliveira AC; Figueiredo-Mendes C; Lanzoni V; Martins J; Nader H; Ferraz ML
Liver Int; 2006 Nov; 26(9):1095-9. PubMed ID: 17032410
[TBL] [Abstract][Full Text] [Related]
9. Serum hyaluronan and laminin level in children with chronic hepatitis B during long-term lamivudine treatment.
Lebensztejn DM; Skiba E; Sobaniec-Lotowska ME; Kaczmarski M
Hepatogastroenterology; 2007; 54(75):834-8. PubMed ID: 17591074
[TBL] [Abstract][Full Text] [Related]
10. Serum markers for necroinflammatory activity in patients with chronic viral hepatitis and normal or mildly elevated aminotransferase levels.
Cheong JY; Kim DJ; Hwang SG; Yang JM; Kim YB; Park YN; Cho SW
Liver Int; 2011 Oct; 31(9):1352-8. PubMed ID: 21745311
[TBL] [Abstract][Full Text] [Related]
11. Diabetes mellitus in chronic hepatitis B and C: prevalence and potential association with the extent of liver fibrosis.
Papatheodoridis GV; Chrysanthos N; Savvas S; Sevastianos V; Kafiri G; Petraki K; Manesis EK
J Viral Hepat; 2006 May; 13(5):303-10. PubMed ID: 16637860
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic value of serum biochemical markers for liver fibrosis in patients with hepatitis B virus].
Huang W; Gong FY
Di Yi Jun Yi Da Xue Xue Bao; 2002 Nov; 22(11):1034-6. PubMed ID: 12433643
[TBL] [Abstract][Full Text] [Related]
13. Assessing routine and serum markers of liver fibrosis in CHB patients using parallel and serial interpretation.
Hongbo L; Xiaohui L; Hong K; Wei W; Yong Z
Clin Biochem; 2007 May; 40(8):562-6. PubMed ID: 17362902
[TBL] [Abstract][Full Text] [Related]
14. [Study on the influence factors of the serum fibrosis markers].
Cai WM; Tao J; Weng HL; Liu RH
Zhonghua Gan Zang Bing Za Zhi; 2003 Jan; 11(1):23-5. PubMed ID: 12546736
[TBL] [Abstract][Full Text] [Related]
15. [Aspartate aminotransferase (AST) more than alanine aminotransferase (ALT) levels predict the progression of liver fibrosis in chronic HCV infection].
Stránský J; Ryzlová M; Striteský J; Horák J
Vnitr Lek; 2002 Oct; 48(10):924-8. PubMed ID: 16737138
[TBL] [Abstract][Full Text] [Related]
16. Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B.
Shin WG; Park SH; Jang MK; Hahn TH; Kim JB; Lee MS; Kim DJ; Jun SY; Park CK
Dig Liver Dis; 2008 Apr; 40(4):267-74. PubMed ID: 18055281
[TBL] [Abstract][Full Text] [Related]
17. Non-invasive models for predicting histology in patients with chronic hepatitis B.
Wai CT; Cheng CL; Wee A; Dan YY; Chan E; Chua W; Mak B; Oo AM; Lim SG
Liver Int; 2006 Aug; 26(6):666-72. PubMed ID: 16842322
[TBL] [Abstract][Full Text] [Related]
18. Serum concentration of transforming growth factor (TGF)-beta 1 does not predict advanced liver fibrosis in children with chronic hepatitis B.
Lebensztejn DM; Sobaniec-Lotowska M; Kaczmarski M; Werpachowska I; Sienkiewicz J
Hepatogastroenterology; 2004; 51(55):229-33. PubMed ID: 15011870
[TBL] [Abstract][Full Text] [Related]
19. Sequential liver and bone biochemical changes in hyperthyroidism: prospective controlled follow-up study.
Huang MJ; Li KL; Wei JS; Wu SS; Fan KD; Liaw YF
Am J Gastroenterol; 1994 Jul; 89(7):1071-6. PubMed ID: 7912472
[TBL] [Abstract][Full Text] [Related]
20. Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk.
Tahan V; Canbakan B; Balci H; Dane F; Akin H; Can G; Hatemi I; Olgac V; Sonsuz A; Ozbay G; Yurdakul I; Senturk H
Hepatogastroenterology; 2008; 55(85):1433-8. PubMed ID: 18795706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
